Abstract:Tissue engineering technology offers a novel approach for cartilage regeneration to treat osteoarthritis. However, cartilage engineering has not mixed the following advantageous factors together: chondrocytes differentiated from recombinant adeno-associated virus 2-transforming growth factor-beta 1 (rAAV2-TGF-beta 1) transfected mesenchymal stem cells (MSCs) and Arg-Gly-Asp (RGD)-modified nano-poly (epsilon-caprolactone)-block-poly(L-lactic acid) (PCL-b-PLLA), both of which may benefit future clinical application. This study aims to evaluate properties of this cell-scaffold compound in vitro. Canine MSCs obtained from bone marrow was isolated and cultured in vitro, then it was transfected by rAAV2-TGF-beta 1 with the multiplicity of infection (MOI) of 5 x 10(5) v.g./cell and 1 x 10(5) v.g./cell respectively. Chondrification markers, including TGF-beta 1, collagen II and Aggreacan were detected by ELISA, Western blot, RT-PCR and immunocytochemistry respectively. Compared with RGD-modified PCL-b-PLLA scaffold, ultra-structure of RGD-modified nano-PCL-b-PLLA scaffold was determined under scanning electron microscopy (SEM). Third generation of chondrocytes derived from rAAV2-TGF-beta 1 transfected MSCs was seeded on both scaffolds. Cellular morphology, protein quantity and DNA content were compared between the two scaffolds. CanineMSCs appeared spindle-shape and revealed active proliferation. Following rAAV2-TGF-beta 1 transfection, contents of TGF-beta 1, collagen II and Aggreacan were increased. The group transfected by 5 x 10(5) v.g./cell showed higher expression of chondrification markers than the group of 1 x 10(5) v. g./cell at each time point (P < 0.05). Under SEM, poriness of RGD-modified nano-PCL-b-PLLA scaffold was 93%, which was higher than that of non-nanostructured scaffold (86%). Following co-culture with third generation of chondrocytes, cells in RGD-modified nano-PCL-b-PLLA scaffold bound more tightly with each other and had increase in extracellular matrix (ECM) secretion than those in non-nanostructured scaffold. Similarly, DNA and protein contents of chondrocytes increased more on nanostructured scaffold than those on the counterpart (P < 0.05). Visual observation found the size and hardness of cell-nanostructured scaffold compound were similar to its previous status, while its surface was smoother and glossier. A large quantity of chondrocytes entered into the nanostructured scaffold and secreted massive ECM. Engineered cartilage combining rAAV2-TGF-beta 1 transfected MSCs-derived chondrocytes with RGD-modified nano-PCL-b-PLLA scaffold can be successfully constructed in vitro with satisfying properties, revealing a preferable choice in cartilage tissue engineering.

The engineered TGF-β3 promoted the differentiation of chondrogenic progenitor cells into chondrocytes in vitro

The promotion of chondrogenesis of marrow stromal stem cells by Transforming growth factor-β3 fusion protein in vitro

Induction of Chondrogenesis of Adipose-Derived Stem Cells by Novel Recombinant TGF-β3 Fusion Protein.

Promotion of Chondrogenesis of Marrow Stromal Stem Cells by TGF-β3 Fusion Protein in Vitro

Gene transfection to induce in vitro chondrogenesis of human bone marrow-derived mesenchymal progenitor cells

Controlled chondrogenesis from adipose-derived stem cells by recombinant transforming growth factor-β3 fusion protein in peptide scaffolds.

Chondrogenic Effect of Precartilaginous Stem Cells Following NLS-TAT Cell Penetrating Peptide-Assisted Transfection of Eukaryotic Htgfβ3

In Vitro Chondrogenesis of Human Bone Marrow-Derived Mesenchymal Progenitor Cells in Monolayer Culture: Activation by Transfection with TGF-β2

Molecular Tissue Engineering:Effect of Transforming Growth Factor Β1 Gene Transfer on the Bioactivity of Mesenchymal Stem Cells

Construction of Tissue-Engineered Cartilage Combining Chondrocytes Induced by Raav2-Tgf-β1 Transfected MSCs with RGD-Modified Nano-PCL-b-PLLA Scaffolds in Vitro

In Vitro Study of Chondrocyte Redifferentiation with Lentiviral Vector-Mediated Transgenic TGF-β3 and Shrna Suppressing Type I Collagen in Three-Dimensional Culture.

Chondrogenesis induced by bone marrow stromal cells in vitro

Bone Marrow Mesenchymal Stem Cells Combined with Calcium Alginate Gel Modified by Htgf-Β1 for the Construction of Tissue-Engineered Cartilage in Three-Dimensional Conditions

Porous chitosan-gelatin scaffold containing plasmid DNA encoding transforming growth factor-β1 for chondrocytes proliferation

Porous chitosan scaffolds with embedded hyaluronic acid/chitosan/plasmid-DNA nanoparticles encoding TGF-β1 induce DNA controlled release, transfected chondrocytes, and promoted cell proliferation.

Recombinant Htgf-Β1 Adenovirus Transfect Bone Marrow Mesenchymal Stem Cells and the Change of TAZ Mrna Expression

Co-Culture of Adipose-Derived Stem Cells and Chondrocytes With Transforming Growth Factor-Beta 3 Promotes Chondrogenic Differentiation

Reparation of articular cartilage defects by using transforming growth factor-beta 1 and cartilage-derived morphogenetic protein-1

Porous Chitosan Scaffolds With Embedded Hyaluronic Acid/Chitosan/Plasmid-Dna Nanoparticles Encoding Tgf-Beta 1 Induce Dna Controlled Release, Transfected Chondrocytes, And Promoted Cell Proliferation

Repair of full-thickness articular cartilage defects by cultured mesenchymal stem cells transfected with the transforming growth factor β<sub>1</sub> gene

Influence of transforming growth factor-β1 inducing time on chondrogenesis of bone marrow stromal cells (BMSCs): In vitro experiment with porcine BMSCs